1. Targeting Rac and Cdc42 GEFs in Metastatic Cancer
    Maria del Mar Maldonado et al, 2020, Front. Cell Dev. Biol. CrossRef
  2. Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL
    Rainer Hubmann et al, 2020, Cells CrossRef
  3. Targeting Notch signaling pathway as an effective strategy in overcoming drug resistance in ovarian cancer
    Maryam Akbarzadeh et al, 2020, Pathology - Research and Practice CrossRef
  4. Notch Transduction in Non-Small Cell Lung Cancer
    Amnah Sharif et al, 2020, IJMS CrossRef

  5. Prognostic Values of Radiosensitivity Genes and CD19 Status in Gastric Cancer: A Retrospective Study Using TCGA Database


    Li-Bo Liang et al, 2020, PGPM CrossRef
  6. Targeting Liver Cancer Stem Cells: An Alternative Therapeutic Approach for Liver Cancer
    Hwa-Yong Lee et al, 2020, Cancers CrossRef
  7. Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancer
    Da-Hyun Kim et al, 2020, BMB Rep. CrossRef
  8. Role of platelets and breast cancer stem cells in metastasis
    Gretel Mendoza-Almanza et al, 2020, WJSC CrossRef
  9. Clinical implications of lung neuroendocrine neoplasm classification
    Jasna Metovic et al, 2020, Expert Review of Anticancer Therapy CrossRef
  10. Major Molecular Signaling Pathways in Oral Cancer Associated With Therapeutic Resistance
    Saima Usman et al, 2021, Front. Oral. Health CrossRef
  11. THE PROSPECT OF USING ONCOGENES’ INHA, DLL4 AND MMP2 ROLE IN DIAGNOSIS AND TREATMENT OF ONCOLOGICAL DISEASE
    I. S. Karlina et al, 2021, Rossijskij bioterapevtičeskij žurnal CrossRef
  12. Molecular Pathology of Pulmonary Large Cell Neuroendocrine Carcinoma: Novel Concepts and Treatments
    Masayo Yoshimura et al, 2021, Front. Oncol. CrossRef
  13. In Silico Logical Modelling to Uncover Cooperative Interactions in Cancer
    Gianluca Selvaggio et al, 2021, IJMS CrossRef
  14. Notch-ing up knowledge on molecular mechanisms of skin fibrosis: focus on the multifaceted Notch signalling pathway
    Angelo Giuseppe Condorelli et al, 2021, J Biomed Sci CrossRef
  15. Molecular Mechanisms of Antiproliferative Effects of Natural Chalcones
    Radka Michalkova et al, 2021, Cancers CrossRef
  16. The Role of Notch3 Signaling in Cancer Stemness and Chemoresistance: Molecular Mechanisms and Targeting Strategies
    Mengxi Xiu et al, 2021, Front. Mol. Biosci. CrossRef
  17. Grand Challenges in Molecular Medicine for Disease Prevention and Treatment Through Cyclical Innovation
    Masuko Katoh et al, 2021, Front. Mol. Med CrossRef
  18. Identification of Novel Metabolism-Associated Subtypes for Pancreatic Cancer to Establish an Eighteen-Gene Risk Prediction Model
    Yang Gao et al, 2021, Front. Cell Dev. Biol. CrossRef
  19. Ovarian Cancer and Cancer Stem Cells—Cellular and Molecular Characteristics, Signaling Pathways, and Usefulness as a Diagnostic Tool in Medicine and Oncology
    Andrzej Nowicki et al, 2021, Cancers CrossRef
  20. Notch1/TAZ axis promotes aerobic glycolysis and immune escape in lung cancer
    Mian Xie et al, 2021, Cell Death Dis CrossRef
  21. Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives
    Nadezda Zhdanovskaya et al, 2021, Cancers CrossRef
  22. Notch signaling in oral pre-cancer and oral cancer
    Kumud Nigam et al, 2021, Med Oncol CrossRef
  23. Druggable Molecular Pathways in Chronic Lymphocytic Leukemia
    Mohammad Almasri et al, 2022, Life CrossRef
  24. Into the Tissues: Extracellular Matrix and Its Artificial Substitutes: Cell Signalling Mechanisms
    Aleksandra Bandzerewicz et al, 2022, Cells CrossRef
  25. Elevated Kir2.1/nuclear N2ICD defines a highly malignant subtype of non-WNT/SHH medulloblastomas
    Yan-Xia Wang et al, 2022, Sig Transduct Target Ther CrossRef
  26. Notch Signaling and Cross-Talk in Hypoxia: A Candidate Pathway for High-Altitude Adaptation
    Katie A. O’Brien et al, 2022, Life CrossRef
  27. The Tumor Microenvironment Drives Intrahepatic Cholangiocarcinoma Progression
    Serena Mancarella et al, 2022, IJMS CrossRef
  28. Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
    Yue Zheng et al, 2022, Front. Oncol. CrossRef
  29. Targeting TMEM88 as an Attractive Therapeutic Strategy in Malignant Tumors
    Ming Cai et al, 2022, Front. Oncol. CrossRef
  30. Notch Signaling in Breast Tumor Microenvironment as Mediator of Drug Resistance
    Adele Chimento et al, 2022, IJMS CrossRef
  31. Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma
    Qikai Zhang et al, 2022, Front. Oncol. CrossRef
  32. Near-Infrared Photoimmunotherapy for Thoracic Cancers: A Translational Perspective
    Kohei Matsuoka et al, 2022, Biomedicines CrossRef
  33. Homo and Heterotypic Cellular Cross-Talk in Epithelial Ovarian Cancer Impart Pro-Tumorigenic Properties through Differential Activation of the Notch3 Pathway
    Souvik Mukherjee et al, 2022, Cancers CrossRef
  34. Research Progress on the Regulation Mechanism of Key Signal Pathways Affecting the Prognosis of Glioma
    Hao Wu et al, 2022, Front. Mol. Neurosci. CrossRef
  35. Generation of synthetic antibody fragments with optimal complementarity determining region lengths for Notch-1 recognition
    Bharathikumar Vellalore Maruthachalam et al, 2022, Front. Microbiol. CrossRef
  36. DDX5 and DDX17—multifaceted proteins in the regulation of tumorigenesis and tumor progression
    Kun Xu et al, 2022, Front. Oncol. CrossRef
  37. Gene signature of m6A-related targets to predict prognosis and immunotherapy response in ovarian cancer
    Wei Tan et al, 2022, J Cancer Res Clin Oncol CrossRef
  38. NOTCH gene alterations in metastatic colorectal cancer in the Nationwide Cancer Genome Screening Project in Japan (SCRUM-Japan GI-SCREEN)
    Takeshi Kajiwara et al, 2022, J Cancer Res Clin Oncol CrossRef
  39. Somatic Mutational Landscape in Mexican Patients: CDH1 Mutations and chr20q13.33 Amplifications Are Associated with Diffuse-Type Gastric Adenocarcinoma
    Dennis Cerrato-Izaguirre et al, 2022, IJMS CrossRef
  40. Crenigacestat (LY3039478) inhibits osteogenic differentiation of human valve interstitial cells from patients with aortic valve calcification in vitro
    Arseniy A. Lobov et al, 2022, Front. Cardiovasc. Med. CrossRef
  41. The prognostic value and immunological role of angiogenesis-related patterns in colon adenocarcinoma
    Weijie Sun et al, 2022, Front. Oncol. CrossRef
  42. Potential of Theranostics in Visualisation of the Tumour Microenvironment and Elimination of Its Immunosuppressive Components
    O. E. Molchanov et al, 2022, Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo primeneniya CrossRef
  43. Activation of Notch signaling in endothelium cause upregulation of N-terminal acetylated histone 1
    A. A. Lobov et al, 2023, Kompleks. probl. serdečno-sosud. zabol. CrossRef
  44. Features of the microenvironment of oncourological tumors
    Oleg E. Molchanov et al, 2023, Urology reports (St. - Petersburg) CrossRef
  45. Comprehensive Molecular Analyses of Notch Pathway-Related Genes to Predict Prognosis and Immunotherapy Response in Patients with Gastric Cancer
    Yinsen Song et al, 2023, Journal of Oncology CrossRef
  46. Melanoma molecular subtyping and scoring model construction based on ligand-receptor pairs
    Zexu Lin et al, 2023, Front. Genet. CrossRef
  47. Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancer
    Sujin Park et al, 2023, JPTM CrossRef
  48. The Intricate Notch Signaling Dynamics in Therapeutic Realms of Cancer
    Plaboni Sen et al, 2023, ACS Pharmacol. Transl. Sci. CrossRef
  49. The Role of the Notch Signaling Pathway in Pathogenesis of Lung Diseases with Noninfectious Etiology
    V. A. Serebryakova et al, 2023, Cell Tiss. Biol. CrossRef
  50. The diagnostic and therapeutic potential of exosomal proteins in breast cancer
    A. A. Shefer et al, 2023, Usp. mol. onkol CrossRef